Overall rank by patents
#26,826
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Medhab ranks #26,826 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R26826 · US Corporation #26,826 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
MedHab · this assignee
25 score
3D Lighting… · lowest
7 score
What this shows Medhab's Innovation Score is 25.1/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
MedHab, LLC is a focused PatentsView assignee: 12 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Medhab sits between Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch and Medicenna Therapeutics Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch
10 patents
Maxar Intelligence Inc.
10 patents
Maxout Renewable, Inc.
10 patents
Measurement Specialties (Chengdu) Ltd
10 patents
MediSynergics, LLC
10 patents
MediVena Sp. z o.o.
10 patents
Medicasafe, Inc.
10 patents
Medicenna Therapeutics Inc.
10 patents
MedHab, LLC
10 patents
What this shows MedHab holds 10 patents at rank #26,869, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,869 in granted patent volume.
Other assignees with the most granted patents in MedHab's primary technology class.
Medhab's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 16th percentile higher than 16% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2017 | 1 | 10.0% |
| 2018 | 2 | 20.0% |
| 2019 | 4 | 40.0% |
| 2020 | 1 | 10.0% |
Top 12 of 12 technology areas
Overall rank by patents
#26,826
of 49,997 tracked assignees
25.1 out of 100
What to do with this data
MedHab, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.